Abstract
Advanced glycation end product (AGE)-their receptor (RAGE) and angiotensin II (AII) are implicated in diabetic retinopathy. However, a crosstalk between the two is not fully understood. In vivo, AGE injection stimulated RAGE expression in the eye of spontaneously hypertensive rats, which was blocked by an AII-type 1 receptor blocker, telmisartan. In vitro, AII-type 1 receptor-mediated reactive oxygen species generation elicited RAGE gene expression in pericytes through NF-κB activation. Further, AII augmented AGE-induced pericyte apoptosis, the earliest hallmark of diabetic retinopathy. Our present study may implicate a crosstalk between AGE-RAGE system and AII in diabetic retinopathy.
Original language | English |
---|---|
Pages (from-to) | 4265-4270 |
Number of pages | 6 |
Journal | FEBS Letters |
Volume | 579 |
Issue number | 20 |
DOIs | |
Publication status | Published - 2005 Aug 15 |
Externally published | Yes |
Keywords
- Advanced glycation end products
- Angiotensin II
- Diabetic retinopathy
- Oxidative stress
- Pericyte loss
- Receptor for AGEs
ASJC Scopus subject areas
- Biophysics
- Structural Biology
- Biochemistry
- Molecular Biology
- Genetics
- Cell Biology